Here are five key notes:
1. The patent covers demineralized bone matrices derived from cortical bone.
2. The technology covered in the patent is used in Bacterin’s OsteoSTX, OsteoWrap and OrbitalWrap HD branded product lines.
3. The company has patent applications pending in the United States to protect other aspects of its allograft processing and demineralization techniques.
4. The patent processing technologies are designed for the allografts to expose native growth factors inherent to natural human bone. The enhanced biological activity promotes rapid healing via tissue regeneration in bone-grafting procedures.
5. Clinical investigators show Bacterin’s patented demineralized bone grafts have fusion rates higher than 97 percent in peer-reviewed, published studies.
More articles on orthopedic devices:
Frankfurt University Hospital purchases ROSA robotic surgery system
Alexander Bone & Spine in Miami offering SCS implants
TranS1 names new vice president of sales
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
